Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.

Lende TH, Austdal M, Bathen TF, Varhaugvik AE, Skaland I, Gudlaugsson E, Egeland NG, Lunde S, Akslen LA, Jonsdottir K, Janssen EAM, Søiland H, Baak JPA.

BMC Cancer. 2019 Dec 4;19(1):1183. doi: 10.1186/s12885-019-6393-7.

2.

Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential.

Billdal DC, While PT, Selnaes KM, Sunoqrot MRS, Langørgen S, Bertilsson H, Bathen TF, Elschot M.

J Magn Reson Imaging. 2019 Dec 3. doi: 10.1002/jmri.27011. [Epub ahead of print]

PMID:
31794113
3.

Historical Biobanks in Breast Cancer Metabolomics- Challenges and Opportunities.

Madssen TS, Cao MD, Pladsen AV, Ottestad L, Sahlberg KK, Bathen TF, Giskeødegård GF.

Metabolites. 2019 Nov 13;9(11). pii: E278. doi: 10.3390/metabo9110278.

4.

Feasibility of contrast-enhanced MRI derived textural features to predict overall survival in locally advanced breast cancer.

Chronaiou I, Giskeødegård GF, Goa PE, Teruel J, Hedayati R, Lundgren S, Huuse EM, Pickles MD, Gibbs P, Sitter B, Bathen TF.

Acta Radiol. 2019 Nov 19:284185119885116. doi: 10.1177/0284185119885116. [Epub ahead of print] No abstract available.

PMID:
31744303
5.

Correction to: Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI.

Andreassen MMS, Goa PE, Sjøbakk TE, Hedayati R, Eikesdal HP, Deng C, Østlie A, Lundgren S, Bathen TF, Jerome NP.

MAGMA. 2019 Oct 29. doi: 10.1007/s10334-019-00789-5. [Epub ahead of print]

PMID:
31664580
6.

Editor's Note: Estrogen Receptor α Promotes Breast Cancer by Reprogramming Choline Metabolism.

Jia M, Andreassen T, Jensen L, Bathen TF, Sinha I, Gao H, Zhao C, Haldosen LA, Cao Y, Girnita L, Moestue SA, Dahlman-Wright K.

Cancer Res. 2019 Oct 15;79(20):5458. doi: 10.1158/0008-5472.CAN-19-2632. No abstract available.

PMID:
31615812
7.

R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.

Kim J, Moestue SA, Bathen TF, Kim E.

Tomography. 2019 Sep;5(3):308-319. doi: 10.18383/j.tom.2019.00015.

8.

Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI.

Andreassen MMS, Goa PE, Sjøbakk TE, Hedayati R, Eikesdal HP, Deng C, Østlie A, Lundgren S, Bathen TF, Jerome NP.

MAGMA. 2019 Sep 27. doi: 10.1007/s10334-019-00778-8. [Epub ahead of print] Erratum in: MAGMA. 2019 Oct 29;:.

PMID:
31562584
9.

Effect of exercise training on cardiac metabolism in rats with heart failure.

Stølen T, Shi M, Wohlwend M, Høydal MA, Bathen TF, Ellingsen Ø, Esmaeili M.

Scand Cardiovasc J. 2019 Sep 10:1-8. doi: 10.1080/14017431.2019.1658893. [Epub ahead of print]

PMID:
31500456
10.

Metabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity.

Austdal M, Silva GB, Bowe S, Thomsen LCV, Tangerås LH, Bjørge L, Bathen TF, Iversen AC.

Hypertension. 2019 Nov;74(5):1136-1143. doi: 10.1161/HYPERTENSIONAHA.119.13184. Epub 2019 Sep 9.

PMID:
31495279
11.

Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients.

Debik J, Euceda LR, Lundgren S, Gythfeldt HVL, Garred Ø, Borgen E, Engebraaten O, Bathen TF, Giskeødegård GF.

J Proteome Res. 2019 Oct 4;18(10):3649-3660. doi: 10.1021/acs.jproteome.9b00316. Epub 2019 Sep 16.

PMID:
31483662
12.

Effect of Repeated Freeze-Thaw Cycles on NMR-Measured Lipoproteins and Metabolites in Biofluids.

Wang F, Debik J, Andreassen T, Euceda LR, Haukaas TH, Cannet C, Schäfer H, Bathen TF, Giskeødegård GF.

J Proteome Res. 2019 Oct 4;18(10):3681-3688. doi: 10.1021/acs.jproteome.9b00343. Epub 2019 Sep 11.

PMID:
31476120
13.

Prostate-Specific Membrane Antigen PET/Magnetic Resonance Imaging for the Planning of Salvage Radiotherapy in Patients with Prostate Cancer with Biochemical Recurrence After Radical Prostatectomy.

Elschot M, Selnæs KM, Langørgen S, Johansen H, Bertilsson H, Tandstad T, Bathen TF.

PET Clin. 2019 Oct;14(4):487-498. doi: 10.1016/j.cpet.2019.06.003. Epub 2019 Aug 2. Review.

14.

Biomarker Discovery Using NMR-Based Metabolomics of Tissue.

Grinde MT, Giskeødegård GF, Andreassen T, Tessem MB, Bathen TF, Moestue SA.

Methods Mol Biol. 2019;2037:243-262. doi: 10.1007/978-1-4939-9690-2_15.

PMID:
31463850
15.

The effect of sampling procedures and day-to-day variations in metabolomics studies of biofluids.

Giskeødegård GF, Andreassen T, Bertilsson H, Tessem MB, Bathen TF.

Anal Chim Acta. 2019 Nov 12;1081:93-102. doi: 10.1016/j.aca.2019.07.026. Epub 2019 Jul 17.

PMID:
31446969
16.

Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.

Nome ME, Euceda LR, Jabeen S, Debik J, Bathen TF, Giskeødegård GF, Taskén KA, Maelandsmo GM, Halvorsen B, Yndestad A, Borgen E, Garred Ø, Aukrust P, Ueland T, Engebraaten O, Kristensen VN, Tekpli X.

Int J Cancer. 2020 Jan 1;146(1):223-235. doi: 10.1002/ijc.32638. Epub 2019 Oct 8.

PMID:
31444972
17.

Associations of physical activity and sedentary time with lipoprotein subclasses in Norwegian schoolchildren: The Active Smarter Kids (ASK) study.

Jones PR, Rajalahti T, Resaland GK, Aadland E, Steene-Johannessen J, Anderssen SA, Bathen TF, Andreassen T, Kvalheim OM, Ekelund U.

Atherosclerosis. 2019 Sep;288:186-193. doi: 10.1016/j.atherosclerosis.2019.05.023. Epub 2019 Jun 5.

PMID:
31200940
18.

Accuracy of breast cancer lesion classification using intravoxel incoherent motion diffusion-weighted imaging is improved by the inclusion of global or local prior knowledge with bayesian methods.

Vidić I, Jerome NP, Bathen TF, Goa PE, While PT.

J Magn Reson Imaging. 2019 Nov;50(5):1478-1488. doi: 10.1002/jmri.26772. Epub 2019 May 9.

PMID:
31070842
19.

Breast cancer quantitative proteome and proteogenomic landscape.

Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF, Schlichting E, Naume B; Consortia Oslo Breast Cancer Research Consortium (OSBREAC), Luders T, Borgen E, Kristensen VN, Russnes HG, Lingjærde OC, Mills GB, Sahlberg KK, Børresen-Dale AL, Lehtiö J.

Nat Commun. 2019 Apr 8;10(1):1600. doi: 10.1038/s41467-019-09018-y.

20.

The Effect of Exercise Training on Myocardial and Skeletal Muscle Metabolism by MR Spectroscopy in Rats with Heart Failure.

Shi M, Ellingsen Ø, Bathen TF, Høydal MA, Stølen T, Esmaeili M.

Metabolites. 2019 Mar 19;9(3). pii: E53. doi: 10.3390/metabo9030053.

21.

Skeletal muscle metabolism in rats with low and high intrinsic aerobic capacity: Effect of aging and exercise training.

Shi M, Ellingsen Ø, Bathen TF, Høydal MA, Koch LG, Britton SL, Wisløff U, Stølen TO, Esmaeili M.

PLoS One. 2018 Dec 11;13(12):e0208703. doi: 10.1371/journal.pone.0208703. eCollection 2018.

22.

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer.

Esmaeili M, Tayari N, Scheenen T, Elschot M, Sandsmark E, Bertilsson H, Heerschap A, Selnæs KM, Bathen TF.

Front Oncol. 2018 Nov 15;8:516. doi: 10.3389/fonc.2018.00516. eCollection 2018.

23.

Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.

Madssen TS, Thune I, Flote VG, Lundgren S, Bertheussen GF, Frydenberg H, Wist E, Schlichting E, Schäfer H, Fjøsne HE, Vettukattil R, Lømo J, Bathen TF, Giskeødegård GF.

Br J Cancer. 2018 Oct;119(9):1144-1154. doi: 10.1038/s41416-018-0211-x. Epub 2018 Nov 7.

24.

Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.

Bousquet PA, Meltzer S, Sønstevold L, Esbensen Y, Dueland S, Flatmark K, Sitter B, Bathen TF, Seierstad T, Redalen KR, Eide L, Ree AH.

Transl Oncol. 2019 Jan;12(1):76-83. doi: 10.1016/j.tranon.2018.09.010. Epub 2018 Sep 29.

25.

Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma.

Andersen MK, Rise K, Giskeødegård GF, Richardsen E, Bertilsson H, Størkersen Ø, Bathen TF, Rye M, Tessem MB.

Sci Rep. 2018 Sep 24;8(1):14269. doi: 10.1038/s41598-018-32549-1.

26.

NMR-Based Prostate Cancer Metabolomics.

Euceda LR, Andersen MK, Tessem MB, Moestue SA, Grinde MT, Bathen TF.

Methods Mol Biol. 2018;1786:237-257. doi: 10.1007/978-1-4939-7845-8_14.

PMID:
29786797
27.

The Effect of Including Bone in Dixon-Based Attenuation Correction for 18F-Fluciclovine PET/MRI of Prostate Cancer.

Elschot M, Selnæs KM, Johansen H, Krüger-Stokke B, Bertilsson H, Bathen TF.

J Nucl Med. 2018 Dec;59(12):1913-1917. doi: 10.2967/jnumed.118.208868. Epub 2018 May 4.

28.

Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized.

Rye MB, Bertilsson H, Andersen MK, Rise K, Bathen TF, Drabløs F, Tessem MB.

BMC Cancer. 2018 Apr 27;18(1):478. doi: 10.1186/s12885-018-4373-y.

29.

NMR-based metabolomics of biofluids in cancer.

Giskeødegård GF, Madssen TS, Euceda LR, Tessem MB, Moestue SA, Bathen TF.

NMR Biomed. 2018 Apr 19:e3927. doi: 10.1002/nbm.3927. [Epub ahead of print]

PMID:
29672973
30.

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.

Søgaard CK, Moestue SA, Rye MB, Kim J, Nepal A, Liabakk NB, Bachke S, Bathen TF, Otterlei M, Hill DK.

Oncotarget. 2018 Jan 27;9(14):11752-11766. doi: 10.18632/oncotarget.24357. eCollection 2018 Feb 20.

31.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB.

Br J Cancer. 2018 Mar 20;118(6):e11. doi: 10.1038/bjc.2017.470. Epub 2018 Feb 20.

32.

Prediction of Clinical Endpoints in Breast Cancer Using NMR Metabolic Profiles.

Euceda LR, Haukaas TH, Bathen TF, Giskeødegård GF.

Methods Mol Biol. 2018;1711:167-189. doi: 10.1007/978-1-4939-7493-1_9.

PMID:
29344890
33.

18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients.

Selnæs KM, Krüger-Stokke B, Elschot M, Willoch F, Størkersen Ø, Sandsmark E, Moestue SA, Tessem MB, Halvorsen D, Kjøbli E, Angelsen A, Langørgen S, Bertilsson H, Bathen TF.

Eur Radiol. 2018 Aug;28(8):3151-3159. doi: 10.1007/s00330-017-5213-1. Epub 2018 Jan 2.

PMID:
29294158
34.

Non-Invasive Prostate Cancer Characterization with Diffusion-Weighted MRI: Insight from In silico Studies of a Transgenic Mouse Model.

Hill DK, Heindl A, Zormpas-Petridis K, Collins DJ, Euceda LR, Rodrigues DN, Moestue SA, Jamin Y, Koh DM, Yuan Y, Bathen TF, Leach MO, Blackledge MD.

Front Oncol. 2017 Dec 1;7:290. doi: 10.3389/fonc.2017.00290. eCollection 2017.

35.

Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.

Kim J, Kim E, Euceda LR, Meyer DE, Langseth K, Bathen TF, Moestue SA, Huuse EM.

J Magn Reson Imaging. 2018 Jun;47(6):1589-1600. doi: 10.1002/jmri.25898. Epub 2017 Dec 4.

PMID:
29205621
36.

Relative enhanced diffusivity: noise sensitivity, protocol optimization, and the relation to intravoxel incoherent motion.

While PT, Teruel JR, Vidić I, Bathen TF, Goa PE.

MAGMA. 2018 Jun;31(3):425-438. doi: 10.1007/s10334-017-0660-x. Epub 2017 Nov 6.

PMID:
29110241
37.

SFRP4 gene expression is increased in aggressive prostate cancer.

Sandsmark E, Andersen MK, Bofin AM, Bertilsson H, Drabløs F, Bathen TF, Rye MB, Tessem MB.

Sci Rep. 2017 Oct 27;7(1):14276. doi: 10.1038/s41598-017-14622-3.

38.

Support vector machine for breast cancer classification using diffusion-weighted MRI histogram features: Preliminary study.

Vidić I, Egnell L, Jerome NP, Teruel JR, Sjøbakk TE, Østlie A, Fjøsne HE, Bathen TF, Goa PE.

J Magn Reson Imaging. 2018 May;47(5):1205-1216. doi: 10.1002/jmri.25873. Epub 2017 Oct 16.

PMID:
29044896
39.

Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer.

Elschot M, Selnæs KM, Sandsmark E, Krüger-Stokke B, Størkersen Ø, Giskeødegård GF, Tessem MB, Moestue SA, Bertilsson H, Bathen TF.

J Nucl Med. 2018 May;59(5):762-768. doi: 10.2967/jnumed.117.198598. Epub 2017 Oct 6.

40.

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB.

Br J Cancer. 2017 Nov 21;117(11):1656-1664. doi: 10.1038/bjc.2017.346. Epub 2017 Oct 3. Erratum in: Br J Cancer. 2018 Feb 20;:.

41.

In vivo MR spectroscopy predicts high tumor grade in endometrial cancer.

Ytre-Hauge S, Esmaeili M, Sjøbakk TE, Grüner R, Woie K, Werner HM, Krakstad C, Bjørge L, Salvesen ØO, Stefansson IM, Trovik J, Bathen TF, Haldorsen IS.

Acta Radiol. 2018 Apr;59(4):497-505. doi: 10.1177/0284185117733297. Epub 2017 Sep 19.

PMID:
28927296
42.

Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.

Nketiah G, Selnaes KM, Sandsmark E, Teruel JR, Krüger-Stokke B, Bertilsson H, Bathen TF, Elschot M.

Magn Reson Med. 2018 May;79(5):2524-2532. doi: 10.1002/mrm.26899. Epub 2017 Sep 1.

PMID:
28862352
43.

High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence.

Tayari N, Steinseifer IK, Selnæs KM, Bathen TF, Maas MC, Heerschap A.

Invest Radiol. 2017 Oct;52(10):640-646. doi: 10.1097/RLI.0000000000000395.

PMID:
28632688
44.

Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.

Haukaas TH, Euceda LR, Giskeødegård GF, Bathen TF.

Metabolites. 2017 May 16;7(2). pii: E18. doi: 10.3390/metabo7020018. Review.

45.

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.

Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E, Sauer T, Mills GB, Kåresen R, Mælandsmo GM, Lingjærde OC, Frigessi A, Kristensen VN, Børresen-Dale AL, Sahlberg KK; OSBREAC.

Breast Cancer Res. 2017 Mar 29;19(1):44. doi: 10.1186/s13058-017-0812-y.

46.

Metabolic Response to Everolimus in Patient-Derived Triple-Negative Breast Cancer Xenografts.

Euceda LR, Hill DK, Stokke E, Hatem R, El Botty R, Bièche I, Marangoni E, Bathen TF, Moestue SA.

J Proteome Res. 2017 May 5;16(5):1868-1879. doi: 10.1021/acs.jproteome.6b00918. Epub 2017 Apr 3.

PMID:
28290700
47.

A novel non-canonical Wnt signature for prostate cancer aggressiveness.

Sandsmark E, Hansen AF, Selnæs KM, Bertilsson H, Bofin AM, Wright AJ, Viset T, Richardsen E, Drabløs F, Bathen TF, Tessem MB, Rye MB.

Oncotarget. 2017 Feb 7;8(6):9572-9586. doi: 10.18632/oncotarget.14161.

48.

T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.

Nketiah G, Elschot M, Kim E, Teruel JR, Scheenen TW, Bathen TF, Selnæs KM.

Eur Radiol. 2017 Jul;27(7):3050-3059. doi: 10.1007/s00330-016-4663-1. Epub 2016 Dec 14.

PMID:
27975146
49.

A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer.

Elschot M, Selnæs KM, Sandsmark E, Krüger-Stokke B, Størkersen Ø, Tessem MB, Moestue SA, Bertilsson H, Bathen TF.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):695-703. doi: 10.1007/s00259-016-3562-7. Epub 2016 Nov 5.

PMID:
27817158
50.

A Simplified Approach to Measure the Effect of the Microvasculature in Diffusion-weighted MR Imaging Applied to Breast Tumors: Preliminary Results.

Teruel JR, Goa PE, Sjøbakk TE, Østlie A, Fjøsne HE, Bathen TF.

Radiology. 2016 Nov;281(2):373-381. Epub 2016 Apr 29.

PMID:
27128662

Supplemental Content

Loading ...
Support Center